Innovative MedTech, Inc. (OTC: IMTH) announced today that it has completed its planned corporate rebranding and name change to AnTix Holdings, Inc., marking a strategic shift from medical technology to the online ticketing and entertainment technology sector. The company, which will continue trading under the ticker symbol “IMTH” for now, aims to leverage artificial intelligence and Web 3.0 tools to improve ticketing and live experiences for consumers and partners.
“This marks an exciting milestone for our Company,” said Michael J. Friedman, President and CEO of AnTix Holdings, Inc. “Through this rebranding, we are expanding into the growing online ticketing and entertainment technology sector, where we see meaningful opportunities to apply artificial intelligence and Web 3.0 tools to improve the ticketing and live experience for consumers and partners alike. Our ticketing technology has begun to generate revenues for the Company and we believe that this will provide a strong foundation for our next phase of growth.”
The name change was effectuated on September 19, 2025, through a Certificate of Amendment filed with the State of Delaware. Outstanding stock certificates remain valid and do not need to be exchanged. The company intends to file with FINRA to change its ticker symbol in the future.
AnTix Holdings is now positioned as a technology company delivering artificial intelligence to online ticketing, with a mission to bring transparency, efficiency, and personalization to the ticketing and entertainment industry. Additionally, the company remains the exclusive licensor for the Oral Thrush application of Shear Kershman Labs’ BioViscid bio-adhesive encapsulation. More information is available at https://www.antixholdings.com.
The rebranding reflects a significant shift in business model, moving away from its original medtech focus. The company believes the ticketing market is ripe for technological change and that its AI and Web 3.0 tools will provide a competitive edge. Friedman emphasized the goal to “build value through innovation, execution and acquisition” and to appeal to a broad base of investors while increasing shareholder value.
This move comes as the company’s ticketing technology has already begun generating revenue, providing a foundation for growth. The announcement underscores the company’s pivot to a sector where it sees meaningful opportunities for disruption and expansion.
